Navigation Links
LABS, Inc. Announces HCT/P ZIKA Virus Screening of Living Donors
Date:4/26/2017

LABS, Inc. (LABS) announced in December 2016 that two new Zika Virus (ZIKV) test offerings were added to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for IgM and IgG ZIKV antibodies. At that time, LABS was only able to offer NAT screening for blood donors under an Investigational New Drug (IND) study protocol.

Now, as part of an ongoing commitment to enabling customers’ safe and timely decisions by delivering the highest quality, most accurate laboratory services, LABS is pleased to announce a third ZIKV test offering. LABS is participating in a second IND, with Grifols, a leader in the lab assay market, which will encompass HCT/P screening of living, or “heart-beating” donors. The results are to be used for Investigational Use Only and are not to be used to aid in diagnosis. While the healthcare community awaits final FDA Guidelines, this IND ZIKV option is intended to provide LABS customers with the most up-to-date products and services. If your organization is interested in ZIKV testing, please contact LABS.

For additional information about ZIKV, please visit the U.S. Food and Drug Administration or Centers for Disease Control and Prevention.

About LABS, Inc.
Founded in 1978, LABS provides laboratory services specialized for transplantation and biomedical applications. Our mission is to enable customers’ safe and timely decisions by delivering the highest quality, most accurate laboratory services. We hold an extensive list of registrations, accreditations and licensures including the American Association of Blood Banks (AABB), Clinical Laboratory Improvement Amendments (CLIA), and the U.S. Food and Drug Administration (FDA). We combine our industry-leading credentials with a customer consultative approach to deliver precisely what’s needed, when and how it’s needed. As a result, our customers are able to make safe, informed and prompt decisions that impact their business, and the lives of those they serve. At LABS, we look beyond the testing to what is possible as the result of it. Lives are at stake, innovation is impacted and potential is effected. What we do matters, but what our customers do with it matters even more. LABS. Realize the potential. For more information, please visit our website.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14278908.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Calvert Labs, Inc. Announces Key Appointment
2. GlassesOff Inc. Renamed InnoVision Labs, Inc., New Trading Symbol INVS
3. Neogenis Labs, a World Leader in Nitric Oxide Innovation, Named to Inc. 5000 Fastest Growth Company List
4. DNA Diagnostics Center, One of The Worlds Largest DNA Testing Labs, Celebrates Their 20th Anniversary
5. CannLabs, Inc. to Create Custom Content Channel on theCannabist.co
6. Michele Rickard Appointed to Vice President- Quality and Continuous Improvement at UAS Labs, The Probiotic Company
7. Labs, Industry Join Forces to Train Cyber Defenders for Nation's Critical Cyber Infrastructure
8. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
9. MSP Corporation Announces a New Breakthrough in Monodisperse Droplet Generation
10. Optofluidics Announces Name Change to Halo Labs
11. Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial in 81 Patients with Panic Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2019)... Ill. (PRWEB) , ... January 15, 2019 , ... Personalized ... factors for worsening kidney disease, according to a new study published in the journal ... and are frequently treated with partial nephrectomy, a surgical procedure in which the tumor ...
(Date:1/11/2019)... ... ... Drawing on over 22 years of software development expertise, the live webinar ... the key lessons that have driven customer satisfaction with their eClinical suite. Explore the ... how to ensure that you continue to be able to take advantage of the ...
(Date:1/10/2019)... ... ... VGI Medical was founded in 2007 based on an invention developed by ... including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed ... design to limit motion of the affected spinal segment. Applying the principles of this ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is ... Disease. The trial took place in South Korea. , This Phase 1 ...
Breaking Biology Technology:
(Date:1/20/2019)... ... January 18, 2019 , ... Boston-based Laboratory as a ... in an effort to better express its continued expansion and service offerings for biotech ... a new kind of lab: one that is more agile and adaptable than ever ...
(Date:1/10/2019)... N.J. (PRWEB) , ... January 10, 2019 , ... ... to improve the translational gap between inexpensive in vitro studies and significantly more ... prediction of in vivo efficacy and toxicity. To address this need, researchers have ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... and leading supplier of Graph Database technology for Knowledge Graphs solutions, announced that ... 2019 ‘Trend-Setting’ Product . DBTA’s data and information management recognition list ...
Breaking Biology News(10 mins):